Picture of Stratec SE logo

SBS Stratec SE Cashflow Statement

0.000.00%
de flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapFalling Star

Annual cashflow statement for Stratec SE, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
C2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line4029.215.416-0.242
Depreciation
Deferred Taxes
Non-Cash Items10.416.37.9111.414.3
Unusual Items
Other Non-Cash Items
Changes in Working Capital-5.95-50.7-22.9-0.26-40.3
Change in Other Assets
Change in Accounts Payable
Other Operating Cash Flow
Cash from Operating Activities63.510.319.348.7-0.433
Capital Expenditures-20.2-19-17.3-18.2-16.2
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items0.1050.022-26.72.22-0.574
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Cash from Investing Activities-20.1-19-44.1-16-16.8
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-34.3-14.135.4-20.3-6.3
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash9.62-24.510.913.6-24.1